MLEC
Moolec Science S.A.NASDAQHealthcare$6.95+64.60%ClosedMarket Cap: $5.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.07
P/S
0.02
EV/EBITDA
-3.69
DCF Value
$3,195.75
FCF Yield
-362.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.2%
Operating Margin
-3.1%
Net Margin
-33.4%
ROE
376.8%
ROA
-54.4%
ROIC
-5.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2024 | $333.6M | 34.2% | $-10.5M | $-111.5M | $-258.75 | — |
| Q2 2024 | $2.6M | -25.5% | $-2.1M | $-2.4M | $-0.90 | — |
| Q1 2024 | $1.6M | 0.9% | $-2.1M | $-1.9M | $-0.75 | — |
| Q4 2023 | $1.5M | -4.7% | $-2.9M | $-2.5M | $-1.05 | — |
| FY 2023 | $5.6M | 8.4% | $-9.0M | $-7.3M | $-2.85 | — |
| Q3 2023 | $2.1M | 4.3% | $-2.0M | $-1.4M | $-0.60 | — |
| Q2 2023 | $252.1K | -3.6% | $-2.0M | $-1.8M | $-0.75 | — |
| Q1 2023 | $1.7M | 12.7% | $-2.3M | $-1.6M | $-0.60 | — |
| Q4 2022 | $905.0K | -15.8% | $-548.4K | $-2.7M | $-1.10 | — |
| FY 2022 | $905.0K | -15.8% | $-6.7M | $-51.8M | $-22.50 | — |
| Q3 2022 | $0.00 | NaN% | $-444.7K | $-358.6K | $-0.15 | — |
| Q2 2022 | $0.00 | NaN% | $-4.9M | $-48.0M | $-19.20 | — |